P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci184514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Cesar L Moreno und 24 weiteren Autor:innen. Beteiligte Einrichtung: Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre and School of Life and Environmental Sciences, The University of Sydney, …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Blood Platelets, P-Selectin. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The physiology of SARS-CoV-2 virus/host interactions is not well understood. To better understand host/virus interactions, we performed a CRISPR activation screen to identify host genes that confer resistance to authentic SARS-CoV-2. This highlighted 34 new candidate genes that may alter the course of infection. We validated that 7 of these genes can suppress authentic SARS-CoV-2 infection, including the innate immune receptor P selectin, which increases SARS-CoV-2 spike-dependent binding to cells, while protecting from infection. P selectin also promotes binding to SARS-CoV-2 variants, SARS-CoV-1, and Middle East respiratory syndrome spike proteins, suggesting a general role for P selectin in highly pathogenic coronavirus infections. Importantly, P selectin protein expression driven by synthetic mRNA can block SARS-CoV-2 infection. Naturally, P selectin is expressed on platelets, and we show that it promotes spike-mediated platelet aggregation. P selectin is also expressed on the endothelium, where SARS-CoV-2 spike interactions are also P selectin dependent. In vivo, SARS-CoV-2 uses P selectin to home to capillary beds where the virus interacts with platelets and endothelium, and blocking this interaction can clear vascular-associated pulmonary SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre and School of Life and Environmental Sciences, The University of Sydney, Sydney, New South Wales, Australia.
- Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
- Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
- Centenary Institute and Faculty of Medicine and Health.
- Haematology Research Lab, Heart Research Institute, and.
- Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Zitieren
APA
Moreno, C. L., Castanheira, F. V., Ospina Stella, A., Chung, F., Aggarwal, A., Cole, A. J., Loo, L., Dupuy, A., Kong, Y. X., Hagimola, L., Fenwick, J., Coleman, P. R., Carr, R., Du, T. Y., Ison, T., Newton, M., Bui-Marinos, M. P., Cohen, S. B., Corcoran, J. A., …, & Neely, G. G. (2025). P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium. Journal of Clinical Investigation. https://doi.org/10.1172/jci184514
Vancouver
Moreno CL, Castanheira FV, Ospina Stella A, Chung F, Aggarwal A, Cole AJ, et al. P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium. Journal of Clinical Investigation. 2025. doi:10.1172/jci184514
BibTeX
@article{Moreno2025,
author = {Moreno, Cesar L and Castanheira, Fernanda Vs and Ospina Stella, Alberto and Chung, Felicity and Aggarwal, Anupriya and Cole, Alexander J and Loo, Lipin and Dupuy, Alexander and Kong, Yvonne X and Hagimola, Lejla and Fenwick, Jemma and Coleman, Paul R and Carr, Rebecca and Du, Tian Y and Ison, Tim and Newton, Michelle and Bui-Marinos, Maxwell P and Cohen, Scott B and Corcoran, Jennifer A and Hesselson, Daniel and Gamble, Jennifer R and Passam, Freda H and Turville, Stuart G and Kubes, Paul and Neely, G Gregory},
title = {P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci184514}
}
EUVIMED